PATENT CLAIM ANALYSIS

Application Number: 15763095
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["514", "171000"]

Abstract:
Bruton's tyrosine kinase (Btk) inhibitors have the following Formula (I):

Claim (Index 7):
A pharmaceutical composition comprising a therapeutically effective amount of the compound of  claim 1 , and a pharmaceutically acceptable excipient.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 90.0
- Lexical Diversity: 1.14286
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13805471', '13780557', '15530681', '14376307', '15410716']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8039371285301252
- 35 USC 102 Novelty (BERT): 0.5421605155643989
- Combined Prediction Score: 0.7777594672335526
- Mean Citation Score: 394.870806
- Max Citation Score: 395.57306
- Similarity Product: 344.68696752725714

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test